Literature DB >> 19949408

The public option. A possible change in US regulatory protocol for genetically modified organisms: compromised or enhanced objectivity?

Jennifer Kuzma1, Zahra Meghani.   

Abstract

Mesh:

Year:  2009        PMID: 19949408      PMCID: PMC2799206          DOI: 10.1038/embor.2009.250

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  6 in total

1.  Science's new social contract with society.

Authors:  M Gibbons
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

2.  Coordinated framework for regulation of biotechnology; announcement of policy; notice for public comment.

Authors: 
Journal:  Fed Regist       Date:  1986-06-26

3.  Laypeople's and experts' perception of nanotechnology hazards.

Authors:  Michael Siegrist; Carmen Keller; Hans Kastenholz; Silvia Frey; Arnim Wiek
Journal:  Risk Anal       Date:  2007-02       Impact factor: 4.000

Review 4.  US regulatory system for genetically modified [genetically modified organism (GMO), rDNA or transgenic] crop cultivars.

Authors:  Alan McHughen; Stuart Smyth
Journal:  Plant Biotechnol J       Date:  2007-10-23       Impact factor: 9.803

5.  Cultural cognition of the risks and benefits of nanotechnology.

Authors:  Dan M Kahan; Donald Braman; Paul Slovic; John Gastil; Geoffrey Cohen
Journal:  Nat Nanotechnol       Date:  2008-12-07       Impact factor: 39.213

6.  Upstream engagement and the governance of science. The shadow of the genetically modified crops experience in Europe.

Authors:  Joyce Tait
Journal:  EMBO Rep       Date:  2009-08       Impact factor: 8.807

  6 in total
  2 in total

1.  Renegotiating GM crop regulation. Targeted gene-modification technology raises new issues for the oversight of genetically modified crops.

Authors:  Jennifer Kuzma; Adam Kokotovich
Journal:  EMBO Rep       Date:  2011-09-01       Impact factor: 8.807

2.  Biosafety data as confidential business information.

Authors:  Kaare M Nielsen
Journal:  PLoS Biol       Date:  2013-03-05       Impact factor: 8.029

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.